289 related articles for article (PubMed ID: 6086840)
1. Cerebral vascular adenylate cyclase: evidence for coupling to receptors for vasoactive intestinal peptide and parathyroid hormone.
Huang M; Rorstad OP
J Neurochem; 1984 Sep; 43(3):849-56. PubMed ID: 6086840
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone stimulates adenylate cyclase in rat cerebral microvessels.
Huang M; Hanley DA; Rorstad OP
Life Sci; 1983 Feb; 32(9):1009-14. PubMed ID: 6827919
[TBL] [Abstract][Full Text] [Related]
3. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
Christophe J; Waelbroeck M; Chatelain P; Robberecht P
Peptides; 1984; 5(2):341-53. PubMed ID: 6089134
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship of parathyroid hormone: relative sensitivity of rabbit renal microvessel and tubule adenylate cyclases to oxidized PTH and PTH inhibitors.
Helwig JJ; Yang MC; Bollack C; Judes C; Pang PK
Eur J Pharmacol; 1987 Aug; 140(3):247-57. PubMed ID: 2820761
[TBL] [Abstract][Full Text] [Related]
5. Synthetic peptides comprising the amino-terminal sequence of a parathyroid hormone-like protein from human malignancies. Binding to parathyroid hormone receptors and activation of adenylate cyclase in bone cells and kidney.
Nissenson RA; Diep D; Strewler GJ
J Biol Chem; 1988 Sep; 263(26):12866-71. PubMed ID: 2843501
[TBL] [Abstract][Full Text] [Related]
6. Effects of PHI on vasoactive intestinal peptide receptors and adenylate cyclase activity in lung membranes. A comparison in man, rat, mouse and guinea pig.
Robberecht P; Tatemoto K; Chatelain P; Waelbroeck M; Delhaye M; Taton G; De Neef P; Camus JC; Heuse D; Christophe J
Regul Pept; 1982 Oct; 4(5):241-50. PubMed ID: 6294750
[TBL] [Abstract][Full Text] [Related]
7. Distribution of parathyroid hormone-sensitive adenylate cyclase in isolated rabbit renal cortex microvessels and glomeruli.
Helwig JJ; Schleiffer R; Judes C; Gairard A
Life Sci; 1984 Dec; 35(26):2649-57. PubMed ID: 6513730
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide effects on GH3 pituitary tumor cells: high affinity binding, affinity labeling, and adenylate cyclase stimulation. Comparison with peptide histidine isoleucine and growth hormone-releasing factor.
Wood CL; O'Dorisio MS; Vassalo LM; Malarkey WB; O'Dorisio TM
Regul Pept; 1985 Nov; 12(3):237-48. PubMed ID: 3001842
[TBL] [Abstract][Full Text] [Related]
9. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
[TBL] [Abstract][Full Text] [Related]
10. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
[TBL] [Abstract][Full Text] [Related]
11. Relaxation of bovine, porcine and human brain arteries by parathyroid hormone.
Suzuki Y; Lederis K; Huang M; LeBlanc FE; Rorstad OP
Life Sci; 1983 Dec; 33(25):2497-503. PubMed ID: 6316066
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the relaxant effects of vasoactive intestinal peptide (VIP) and PHI on isolated brain arteries.
Suzuki Y; McMaster D; Lederis K; Rorstad OP
Brain Res; 1984 Nov; 322(1):9-16. PubMed ID: 6549149
[TBL] [Abstract][Full Text] [Related]
13. Characterization of functional receptors for vasoactive intestinal peptide in bovine cerebral arteries.
Suzuki Y; McMaster D; Huang M; Lederis K; Rorstad OP
J Neurochem; 1985 Sep; 45(3):890-9. PubMed ID: 2993516
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone (PTH) and PTH-related peptide induce relaxation of smooth muscle cells from guinea pig ileum: interaction with vasoactive intestinal peptide receptors.
Botella A; Rekik M; Delvaux M; Davicco MJ; Barlet JP; Frexinos J; Bueno L
Endocrinology; 1994 Nov; 135(5):2160-7. PubMed ID: 7525262
[TBL] [Abstract][Full Text] [Related]
15. Interaction of GRF with VIP receptors and stimulation of adenylate cyclase in rat and human intestinal epithelial membranes. Comparison with PHI and secretin.
Laburthe M; Amiranoff B; Boige N; Rouyer-Fessard C; Tatemoto K; Moroder L
FEBS Lett; 1983 Aug; 159(1-2):89-92. PubMed ID: 6307754
[TBL] [Abstract][Full Text] [Related]
16. Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments.
Waelbroeck M; Robberecht P; De Neef P; Chatelain P; Christophe J
Biochim Biophys Acta; 1981 Nov; 678(1):83-90. PubMed ID: 6272875
[TBL] [Abstract][Full Text] [Related]
17. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
[TBL] [Abstract][Full Text] [Related]
18. Sulfur-free parathyroid hormone analogues containing D-amino acids: biological properties in vitro and in vivo.
Rosenblatt M; Coltrera MD; Shepard GL; Gray DA; Parsons JA; Potts JT
Biochemistry; 1981 Dec; 20(25):7246-50. PubMed ID: 6274393
[TBL] [Abstract][Full Text] [Related]
19. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
20. Evidence for adenylyl cyclase-dependent receptors for parathyroid hormone (PTH)-related protein in rabbit kidney glomeruli.
Massfelder T; Saussine C; Simeoni U; Enanga B; Judes C; Helwig JJ
Life Sci; 1993; 53(11):875-81. PubMed ID: 8396186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
